title: Cisplatin, methotrexate and mitoxantrone in patients with metastatic or advanced urothelial cancer.
authors.affiliation: Department of Oncology, Aarhus University Hospital, Denmark.
authors.forename: L J
authors.initials: LJ
authors.lastname: Andersen
authors.forename: L
authors.initials: L
authors.lastname: Sengeløv
authors.forename: C
authors.initials: C
authors.lastname: Kamby
authors.forename: H
authors.initials: H
authors.lastname: von der Maase
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000401:mortality; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D016896:Treatment Outcome; D014571:Urologic Neoplasms / Q000188:drug therapy* / Q000401:mortality
chemical_list: D008942:Mitoxantrone; D002945:Cisplatin; D008727:Methotrexate